Communiqués Fulgent Genetics, Inc.

Actions

FLGT

US3596641098

Installations et services en soins de santé

Marché Fermé - Nasdaq 22:00:00 21/08/2026			Varia. 5j.	Varia. 1 janv.
19,90 ^USD	-0,10%		+6,70%	-24,25%

30/07	Transcript : Fulgent Genetics, Inc., Q2 2026 Earnings Call, Jul 30, 2026
30/07	Fulgent Genetics, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI

Communiqués

30/07	Fulgent Reports Second Quarter 2026 Financial Results	BU
09/07	Fulgent to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026	BU
02/06	Fulgent Presents Updated FID-007 Data at ASCO 2026	BU
21/05	Fulgent Announces Rapid Oral Full Abstract Publication for FID-007 Within the Head and Neck Cancer Track Session at the ASCO 2026 Annual Meeting	BU
01/05	Fulgent Reports First Quarter 2026 Financial Results	BU
22/04	Fulgent Selected to Present Rapid Oral Abstract Within the Head and Neck Cancer Track Session at the 2026 ASCO Annual Meeting	BU
16/04	Fulgent to Announce First Quarter 2026 Financial Results on Friday, May 1, 2026	BU
17/03	Fulgent Genetics Completes Acquisition of Bako Diagnostics and StrataDx	BU
12/03	Fulgent Genetics : 2026 02 27 Transcript of Fulgent Genetics Inc conference	PU
12/03	Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the Firm	AQ
02/03	Fulgent Genetics, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses	AQ
02/03	Fulgent Reports Fourth Quarter and Full Year 2025 Financial Results	AQ
27/02	Fulgent Reports Fourth Quarter and Full Year 2025 Financial Results	BU
12/02	Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026	BU
22/12	Fulgent Genetics Agrees to Acquire Bako Diagnostics and StrataDx	BU
08/12	Fulgent Genetics : CORRECTED TRANSCRIPT Fulgent Genetics, Inc(FLGT US), Q3 2025 Earnings Call, 7 November 2025 8 30 AM ET	PU
10/11	Fulgent Reports Third Quarter 2025 Financial Results	AQ
10/11	Fulgent to Participate in Upcoming Conferences	AQ
07/11	Fulgent to Participate in Upcoming Conferences	BU
07/11	Fulgent Reports Third Quarter 2025 Financial Results	BU
20/10/25	Fulgent Shares Preliminary Data from Poster Presentation at ESMO 2025 Conference	BU
16/10/25	Fulgent to Announce Third Quarter 2025 Financial Results on Friday, November 7, 2025	BU
04/08/25	Fulgent Genetics : 2025 08 01 FLGTOQ LSEG StreetEvents FLGTOQ Event Transcript of Fulgent Genetics Inc conferenc 116961352	PU
01/08/25	Fulgent Genetics : Investor Presentation	PU
01/08/25	Fulgent Reports Second Quarter 2025 Financial Results	BU